Viral and host factors related to the clinical outcome of COVID-19.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
07 2020
Historique:
received: 14 03 2020
accepted: 13 05 2020
pubmed: 21 5 2020
medline: 22 7 2020
entrez: 21 5 2020
Statut: ppublish

Résumé

In December 2019, coronavirus disease 2019 (COVID-19), which is caused by the new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified in Wuhan (Hubei province, China)

Identifiants

pubmed: 32434211
doi: 10.1038/s41586-020-2355-0
pii: 10.1038/s41586-020-2355-0
doi:

Substances chimiques

Inflammation Mediators 0
Interleukin-6 0
Interleukin-8 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

437-440

Commentaires et corrections

Type : CommentIn

Références

Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020).
doi: 10.1056/NEJMoa2001017 pubmed: 31978945 pmcid: 7092803
Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020).
doi: 10.1038/s41586-020-2012-7 pubmed: 32015507 pmcid: 7095418
Lam, T. T. et al. Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins. Nature (2020).
Li, Q. et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med. 382, 1199–1207 (2020).
doi: 10.1056/NEJMoa2001316 pubmed: 31995857 pmcid: 7121484
Guan, W. J. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708–1720 (2020).
doi: 10.1056/NEJMoa2002032 pubmed: 32109013
Chan, J. F. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395, 514–523 (2020).
doi: 10.1016/S0140-6736(20)30154-9 pubmed: 31986261 pmcid: 7159286
Lu, R. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395, 565–574 (2020).
doi: 10.1016/S0140-6736(20)30251-8 pubmed: 32007145 pmcid: 7159086
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C. & Garry, R. F. The proximal origin of SARS-CoV-2. Nat. Med. 26, 450–452 (2020).
doi: 10.1038/s41591-020-0820-9 pubmed: 32284615
MacLean, O. A., Orton, R., Singer, J. B. & Robertson, D. L. Response to “On the origin and continuing evolution of SARS-CoV-2”,  http://virological.org/t/response-to-on-the-origin-and-continuing-evolution-of-sars-cov-2/418 (2020).
Tang, X. et al. On the origin and continuing evolution of SARS-CoV-2. Natl Sci. Rev. https://doi.org/10.1093/nsr/nwaa036 (2020).
Ren, L. L. et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin. Med. J. (Engl.) 133, 1015–1024 (2020).
doi: 10.1097/CM9.0000000000000722
Wong, R. S. et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. Br. Med. J. 326, 1358–1362 (2003).
doi: 10.1136/bmj.326.7403.1358
Tian, S. et al. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J. Thorac. Oncol. 15, 700–704 (2020).
doi: 10.1016/j.jtho.2020.02.010 pubmed: 32114094 pmcid: 7128866
Xu, Z. et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 8, 420–422 (2020).
doi: 10.1016/S2213-2600(20)30076-X pubmed: 32085846 pmcid: 7164771
Wang, C. et al. Alveolar macrophage activation and cytokine storm in the pathogenesis of severe COVID-19. Preprint at https://doi.org/10.21203/rs.3.rs-19346/v1 (2020).
Shan, C. et al. Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in the Rhesus macaques. Preprint at https://doi.org/10.21203/rs.2.25200/v1 (2020).
National Health Commission of the People’s Republic of China Diagnosis and Treatment Protocol for COVID-19 (Trial Version 7) http://en.nhc.gov.cn/2020-03/29/c_78469.htm (2020).
Quick, J. et al. Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. Nat. Protocols 12, 1261–1276 (2017).
doi: 10.1038/nprot.2017.066 pubmed: 28538739
Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics 25, 1754–1760 (2009).
doi: 10.1093/bioinformatics/btp324 pubmed: 19451168 pmcid: 2705234
Li, H. et al. The sequence alignment/map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
pubmed: 19505943 pmcid: 2723002
Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114–2120 (2014).
doi: 10.1093/bioinformatics/btu170 pubmed: 24695404 pmcid: 4103590
Fedonin, G. G., Fantin, Y. S., Favorov, A. V., Shipulin, G. A. & Neverov, A. D. VirGenA: a reference-based assembler for variable viral genomes. Brief. Bioinform. 20, 15–25 (2019).
doi: 10.1093/bib/bbx079 pubmed: 28968771
Katoh, K. & Standley, D. M. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 30, 772–780 (2013).
doi: 10.1093/molbev/mst010 pubmed: 23329690 pmcid: 3603318
Hadfield, J. et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics 34, 4121–4123 (2018).
doi: 10.1093/bioinformatics/bty407 pubmed: 29790939 pmcid: 6247931
Nguyen, L. T., Schmidt, H. A., von Haeseler, A. & Minh, B. Q. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol. Biol. Evol. 32, 268–274 (2015).
doi: 10.1093/molbev/msu300 pubmed: 25371430
Sagulenko, P., Puller, V. & Neher, R. A. TreeTime: maximum-likelihood phylodynamic analysis. Virus Evol. 4, vex042 (2018).
doi: 10.1093/ve/vex042 pubmed: 29340210 pmcid: 5758920

Auteurs

Xiaonan Zhang (X)

Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

Yun Tan (Y)

National Research Center for Translational Medicine, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University (SJTU) School of Medicine, Shanghai, China.

Yun Ling (Y)

Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

Gang Lu (G)

National Research Center for Translational Medicine, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University (SJTU) School of Medicine, Shanghai, China.

Feng Liu (F)

National Research Center for Translational Medicine, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University (SJTU) School of Medicine, Shanghai, China.

Zhigang Yi (Z)

Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Key Laboratory of Medical Molecular Virology, Shanghai Medical College, Fudan University, Shanghai, China.

Xiaofang Jia (X)

Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

Min Wu (M)

Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

Bisheng Shi (B)

Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

Shuibao Xu (S)

Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

Jun Chen (J)

Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

Wei Wang (W)

Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

Bing Chen (B)

National Research Center for Translational Medicine, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University (SJTU) School of Medicine, Shanghai, China.

Lu Jiang (L)

National Research Center for Translational Medicine, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University (SJTU) School of Medicine, Shanghai, China.

Shuting Yu (S)

National Research Center for Translational Medicine, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University (SJTU) School of Medicine, Shanghai, China.

Jing Lu (J)

National Research Center for Translational Medicine, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University (SJTU) School of Medicine, Shanghai, China.

Jinzeng Wang (J)

National Research Center for Translational Medicine, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University (SJTU) School of Medicine, Shanghai, China.

Mingzhu Xu (M)

Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

Zhenghong Yuan (Z)

Key Laboratory of Medical Molecular Virology, Shanghai Medical College, Fudan University, Shanghai, China.

Qin Zhang (Q)

Tong Ren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Xinxin Zhang (X)

Research Laboratory of Clinical Virology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University (SJTU) School of Medicine, Shanghai, China.

Guoping Zhao (G)

Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.

Shengyue Wang (S)

National Research Center for Translational Medicine, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University (SJTU) School of Medicine, Shanghai, China. wsy12115@rjh.com.cn.

Saijuan Chen (S)

National Research Center for Translational Medicine, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University (SJTU) School of Medicine, Shanghai, China. sjchen@stn.sh.cn.

Hongzhou Lu (H)

Shanghai Public Health Clinical Center, Fudan University, Shanghai, China. luhongzhou@shphc.org.cn.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH